Shaping the Future of HTA in Italy: Insights from the Italian Health Policy Forum [0.03%]
意大利卫生政策论坛展望下的健康技术评估的未来趋势及见解
Paolo Sciattella,Roberta Laurita,Chiara Bini et al.
Paolo Sciattella et al.
The implementation of the European (EU) Health Technology Assessment (HTA) Regulation 2021/2282 (EU HTAR) offers many opportunities, aimed at harmonizing HTA procedures and improving access to innovations; it also represents a significant c...
Shaping the Future of DHT Assessment: Insights on Industry Challenges, Developer Needs, and a Harmonized, European HTA Framework [0.03%]
塑造DHT评估的未来：行业挑战、开发者需求及欧洲统一HTA框架的洞察
Fruzsina Mezei,Emmanouil Tsiasiotis,Michele Basile et al.
Fruzsina Mezei et al.
Introduction: Market access, pricing, and reimbursement of digital health technologies (DHTs) in Europe are significantly challenged by regulatory fragmentation and various assessment methodologies. Understanding the challenges and prioriti...
European Health Technology Assessment Considerations Related to Gene Therapies in Eyecare: The Neovascular Age-Related Macular Degeneration Example [0.03%]
欧洲眼保健相关基因治疗的技术评估考虑因素——以年龄相关性黄斑变性为例
Kevin Douglas,Gianni Pardhanani,Laetitia Mariani et al.
Kevin Douglas et al.
Gene therapies that induce the body to produce therapeutic anti-vascular endothelial growth factor (anti-VEGF) proteins are an emerging topic related to neovascular age-related macular degeneration (nAMD). Continuous delivery of anti-VEGF p...
Deploying Experienced Utility in Health Economic Evaluation: A Quantitative Study [0.03%]
经验效用在卫生经济学评价中的应用：一项定量研究
Damien S E Broekharst,Sjaak Bloem,Robert J Blomme et al.
Damien S E Broekharst et al.
Background: Expected utility has been deployed in order to predict health behaviour in health economic evaluation. However, only limited variance in health behaviour is explained by this construct. This limited explained ...
Vítor Silva,João José Joaquim,Shane Desselle et al.
Vítor Silva et al.
Pharmacy technicians (PT) are vital to the efficient and safe operation of hospital pharmacy services, fulfilling a range of technical and clinical responsibilities that directly impact patient care. However, increasing healthcare demands h...
Value-Based Healthcare as a Competitive Strategy-A Multi-Stakeholder Perception Analysis in Portuguese Healthcare [0.03%]
基于价值的医疗作为竞争战略-葡萄牙医疗保健利益相关者视角分析
Filipe Santiago,Filipe Costa,Eduardo Redondo et al.
Filipe Santiago et al.
Designing an accessible, financially viable healthcare system is a key challenge for society. The value-based healthcare (VBHC) strategic model aims to simultaneously improve the quality of healthcare and the efficiency of health systems. T...
Patient Involvement in Health Technology Assessments: Lessons for EU Joint Clinical Assessments [0.03%]
卫生技术评估中的患者参与：欧盟联合临床评估的启示
Anne-Pierre Pickaert
Anne-Pierre Pickaert
Patient involvement in health technology assessment (HTA) processes is increasingly recognized as pivotal for informed, equitable, and patient-relevant health care decision-making. With the implementation of Joint Scientific Consultations (...
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past? [0.03%]
即将上市的罕见病药物的关键研究：它们能比以往更好地支持卫生技术评估和市场准入吗？
Claudio Jommi,Marzia Bonfanti,Melissa Guardigni et al.
Claudio Jommi et al.
The designs of clinical trials of drugs for rare diseases are challenged by health technology assessment organisations and payers. Phase II pivotal studies, single-arm or open-label designs, the extensive use of non-final endpoints, and the...
Managed Entry Agreements for Pharmaceutical Products in Three Maghreb Countries: Payer and Supplier Perspectives [0.03%]
三个北非国家的医药产品 managed entry agreements：支付方和供应方的观点
Hajer Dahmani,Leila Achour;Maghreb Research Group;Mondher Toumi,Ines Fradi
Hajer Dahmani
Our objective is to describe the experience and challenges of using Managed Entry Agreements (MEAs) in Algeria, Morocco, and Tunisia. We conducted online interviews with key decision-makers in Algeria, Morocco, and Tunisia between March 202...
Preparing for the EU HTA Regulation: Insights from the Dutch Perspective [0.03%]
从荷兰视角看欧盟HTA条例的实施：准备与展望
Anne Willemsen,Maureen Rutten-van Mölken,Riam Al Dulaimi et al.
Anne Willemsen et al.
The European Health Technology Assessment (HTA) regulation (HTAR) came into effect in January 2025 and impacts the HTA process in all European Member States. Member States must give due consideration to the joint clinical assessment (JCA) r...